Skip to content

Clinical trials

Phase 1/2 Lupus Nephritis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Nephritis Phase: Phase 1/2 Country / region: Australia Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alpine Immune Sciences, Inc.1
AstraZeneca1
Kezar Life Sciences, Inc.1
Lyell Immunopharma, Inc.1
Nkarta, Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Nephritis6
Lupus Erythematosus, Systemic4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Churg-Strauss Syndrome1
Glomerulonephritis, IGA1
Glomerulonephritis, Membranous1
Granulomatosis with Polyangiitis1
Microscopic Polyangiitis1
Nephritis1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.